전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,047 programs
AntibodyLimited DatastaleRochePhase 3

GP2013 - A Proposed biosimilar rituximab (GP2013 - A Proposed biosimilar rituximab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleAbbViePhase 3

adalimumab biosimilar (GP2017, GP2017 (adalimumab biosimilar))

Ankylosing Spondylitis · Ankylosing Spondylitis

#AnkylosingSpondylitis#Antibody#Phase3#monoclonal-antibody#AbbVie
Trials 1Status Active
AntibodyLimited DatastaleSandozPhase 3

adalimumab (Humira, GP2017 Adalimumab)

Plaque Type Psoriasis · Plaque Type Psoriasis

#PlaqueTypePsoriasis#Antibody#Phase3#monoclonal-antibody#Sandoz
Trials 1Status Active
CGTLimited DatastaleEssen BiotechPhase 2

GPC3 CD146 CAR-T cells (GPC3 CD146 CAR-T cells)

Ovarian Cancer; Ovarian Carcinoma · Ovarian Cancer

#OvarianCancer#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
AntibodyLimited DatastaleGlenmark Specialty S.A.Phase 1

atezolizumab (Tecentriq, GRC 54276 + Atezolizumab)

Advanced Solid Tumor; Lymphoma · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#monoclonal-antibody#Lymphoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleGlenmark Specialty S.A.Phase 1

pembrolizumab (Keytruda, GRC 54276 + Pembrolizumab)

Advanced Solid Tumor; Lymphoma · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#monoclonal-antibody#Lymphoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleBrightPath BiotherapeuticsPhase 2

pembrolizumab (Keytruda, GRN-1201 + Pembrolizumab)

Metastatic NSCLC · Metastatic NSCLC

#MetastaticNSCLC#Antibody#Phase2#monoclonal-antibody#BrightPath
Trials 1Status Discontinued
AntibodyLimited DatastaleQuantumLeap Healthcare Collabor…Phase 2

GSK 5733584 + Dostarlimab (GSK 5733584 + Dostarlimab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#BreastNeoplasms+2
Trials 1Status Recruiting
CGTAAVLimited DatastaleFederal State Budget Institutio…Phase 2

GT-UGT1A1-AAV8-02 (GT-UGT1A1-AAV8-02)

Crigler-Najjar Syndrome Type I · Crigler-Najjar Syndrome Type I

#Crigler-NajjarSyndromeTypeI#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
AntibodyLimited DatastaleSuzhou Kintor Pharmaceutical In…Phase 2

nivolumab (Opdivo, GT90001 and Nivolumab)

Metastatic Hepatocellular Carcinoma; HCC · Metastatic Hepatocellular Carcinoma

#MetastaticHepatocellularCarcinom#Antibody#Phase2#monoclonal-antibody#HCC+1
Trials 1Status Active
AntibodyLimited DatastaleInsel Gruppe AG, University Hos…Phase 2

durvalumab (Imfinzi, Gemcitabin, Cisplatin and Durvalumab)

Bile Duct Cancer · Bile Duct Cancer

#BileDuctCancer#Antibody#Phase2#monoclonal-antibody#Insel
Trials 1Status Recruiting
AntibodyLimited DatastaleSeoul National University Hospi…Phase 2

nivolumab (Opdivo, Gemcitabine+ nivolumab)

Recurrent or Metastatic Nasopharyngeal Carcinom · Recurrent or Metastatic Nasopharyngeal C

#RecurrentorMetastaticNasopharyng#Antibody#Phase2#monoclonal-antibody#Seoul
Trials 1Status Active
ADCLimited DatastalePfizerPreclinical

GO (Gemtuzumab Ozogamicin, Gemtuzumab Ozogamicin (GO))

Leukemia, Myeloid, Acute · Leukemia, Myeloid, Acute

#LeukemiaMyeloidAcute#ADC#Preclinical#antibody-drug-conjugate#Leukemia+3
Trials 1Status Active
AntibodyLimited DatastaleHenan Provincial People's Hospi…Preclinical

Gene evolution and molecular response under Bevacizumab treatment (Gene evolution and molecular response under Bevacizumab treatment)

Genetic Change · Genetic Change

#GeneticChange#Antibody#Preclinical#monoclonal-antibody#Henan
Trials 1Status Recruiting
CGTLimited DatastaleGenSight BiologicsPhase 2

Gene therapy: GS030-DP AND Medical device: GS030-MD (Gene therapy: GS030-DP AND Medical device: GS030-MD)

Non-syndromic Retinitis Pigmentosa · Non-syndromic Retinitis Pigmentosa

#Non-syndromicRetinitisPigmentosa#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleNational Heart, Lung, and Blood…Phase 2

Gene-Corrected Macrophages administered by bronchoscopic instillation (Gene-Corrected Macrophages administered by bronchoscopic instillation)

Hereditary Pulmonary Alveolar Proteinosis · Hereditary Pulmonary Alveolar Proteinosi

#HereditaryPulmonaryAlveolarProte#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleAllotera TherapeuticsPreclinical

Genetic: WU-CART-007 (Genetic: WU-CART-007)

T-cell Acute Lymphoblastic Leukemia; T-cell Lymphoblastic Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 1Status Active
AntibodyLimited DatastaleChangchun GeneScience Pharmaceu…Phase 1

Gentulizumab (Gentulizumab)

Solid Tumor; Non-Hodgkin Lymphoma · Solid Tumor

#SolidTumor#Antibody#Phase1#monoclonal-antibody#Non-HodgkinLymphoma+1
Trials 1Status Discontinued
CGTLimited DatastaleChinese PLA General HospitalPhase 1

GoFast CD19 CAR T Cells (GoFast CD19 CAR T Cells)

Relapsed or Refractory Large B-cell Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
AntibodyLimited DatastaleHookipa Biotech GmbHPhase 2

pembrolizumab (Keytruda, HB-202 / HB-201 alternating intravenous administration + pembrolizumab.)

HPV-Related Squamous Cell Carcinoma · HPV-Related Squamous Cell Carcinoma

#HPV-RelatedSquamousCellCarcinoma#Antibody#Phase2#monoclonal-antibody#Hookipa
Trials 1Status Active

66 / 103 pages

← PreviousNext →